Modified breast cancer model for preclinical immunotherapy studies

Eriko Katsuta1, Stephanie C DeMasi2, Krista P Terracina2

  • 1Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and The Massey Cancer Center, Richmond, Virginia; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine and The Massey Cancer Center, Richmond, Virginia; Breast Surgery, Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York.

Summary

This study improved orthotopic inoculation of breast cancer cells in mice for immunotherapy research. Matrigel improved tumor growth, and bioluminescence tracked immune rejection in preclinical models.